cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bolt Biotherapeutics Inc
14 own
16 watching
Current Price
$1.15
$0.04
(3.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
51.05M
52-Week High
52-Week High
2.03000
52-Week Low
52-Week Low
0.84000
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
0.01637853
P/E Ratio
P/E Ratio
36.56666667
iconMarket Capitalization51.05M
icon52-Week High2.03000
icon52-Week Low0.84000
iconAverage Volume0.09M
iconDividend Yield0.01637853
iconP/E Ratio36.56666667
What does the Bolt Biotherapeutics Inc do?
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.
Read More
How much money does Bolt Biotherapeutics Inc make?
News & Events about Bolt Biotherapeutics Inc.
Globe Newswire
11 months ago
Comprehensive Phase 1 data at ASCO support initiation of two Phase 2 trialsREDWOOD CITY, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company pioneering novel immuno-oncology therapeutics for the treatment of cancer, today ...
Globe Newswire
1 year ago
REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer, today announced that management will participate in two upcoming conferences in February...
Globe Newswire
1 year ago
REDWOOD CITY, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that it will be presenting a poster with new preclinical data on BDC-3042, a ...
Globe Newswire
1 year ago
- Ex vivo data support the high frequency of myeloid cells in tumors, even when T cells are not present - REDWOOD CITY, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that ...
Frequently Asked Questions
Frequently Asked Questions
What is Bolt Biotherapeutics Inc share price today?
plus_minus_icon
Can Indians buy Bolt Biotherapeutics Inc shares?
plus_minus_icon
How can I buy Bolt Biotherapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Bolt Biotherapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Bolt Biotherapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Bolt Biotherapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Bolt Biotherapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Bolt Biotherapeutics Inc?
plus_minus_icon
What percentage is Bolt Biotherapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Bolt Biotherapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.15
$0.04
(3.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
BEYOND AIR INC
BEYOND AIR INC
$1.18
$-0.10 (-7.81 %)
MINK THERAPEUTICS, INC.
MINK THERAPEUTICS, INC.
$0.87
$-0.04 (-4.86 %)
LUCID DIAGNOSTICS INC.
LUCID DIAGNOSTICS INC.
$0.79
$-0.01 (-1.50 %)
COGNITION THERAPEUTICS, INC.
COGNITION THERAPEUTICS, INC.
$1.82
$-0.08 (-4.21 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
BEYOND AIR INC
BEYOND AIR INC
$1.18
$-0.10 (-7.81 %)
MINK THERAPEUTICS, INC.
MINK THERAPEUTICS, INC.
$0.87
$-0.04 (-4.86 %)
LUCID DIAGNOSTICS INC.
LUCID DIAGNOSTICS INC.
$0.79
$-0.01 (-1.50 %)
COGNITION THERAPEUTICS, INC.
COGNITION THERAPEUTICS, INC.
$1.82
$-0.08 (-4.21 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00